Tianyin Pharmaceutical CO (TPIY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2014 | 06-2013 | 06-2012 | 06-2011 | 06-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -808 | 6,615 | 6,242 | 15,623 | 11,898 |
| Depreciation Amortization | 2,588 | 2,435 | 1,215 | 1,188 | 954 |
| Income taxes - deferred | -1,181 | N/A | N/A | N/A | N/A |
| Accounts receivable | 1,065 | 1,400 | -2,007 | -497 | -2,770 |
| Accounts payable and accrued liabilities | -492 | 1,935 | -1,123 | -525 | 2,239 |
| Other Working Capital | 274 | 3,724 | 438 | -2,977 | 1,067 |
| Other Operating Activity | 1,009 | -3,160 | 3,185 | 1,375 | 2,012 |
| Operating Cash Flow | $2,455 | $12,950 | $7,950 | $14,186 | $15,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,451 | -14,978 | -10 | -12,018 | -5,809 |
| Net Acquisitions | N/A | -207 | -335 | N/A | N/A |
| Purchase Sale Intangibles | -6,973 | -887 | -4,747 | N/A | -2,743 |
| Other Investing Activity | -8,958 | -887 | -4,747 | 302 | -3,036 |
| Investing Cash Flow | $-15,409 | $-16,072 | $-5,092 | $-11,716 | $-8,845 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 4,556 | 10,301 | 3,154 | 1,209 | 66 |
| Debt Repayment | N/A | -4,704 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | N/A | 8,895 |
| Common Stock Repurchased | N/A | N/A | -24 | N/A | N/A |
| Dividend Paid | N/A | N/A | N/A | -143 | -1,409 |
| Other Financing Activity | -2,395 | -11,433 | -3,265 | 0 | 440 |
| Financing Cash Flow | $2,161 | $-5,836 | $-135 | $1,066 | $7,992 |
| Exchange Rate Effect | 86 | 633 | 704 | 1,179 | 110 |
| Beginning Cash Position | 26,827 | 35,152 | 31,725 | 27,009 | 12,352 |
| End Cash Position | 16,120 | 26,827 | 35,152 | 31,725 | 27,009 |
| Net Cash Flow | $-10,707 | $-8,325 | $3,427 | $4,716 | $14,657 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,455 | 12,950 | 7,950 | 14,186 | 15,400 |
| Capital Expenditure | -6,451 | -14,978 | -556 | -12,018 | -5,809 |
| Free Cash Flow | -3,995 | -2,029 | 7,395 | 2,168 | 9,591 |